scispace - formally typeset
K

Keisuke Okita

Researcher at Kyoto University

Publications -  115
Citations -  26472

Keisuke Okita is an academic researcher from Kyoto University. The author has contributed to research in topics: Induced pluripotent stem cell & Embryonic stem cell. The author has an hindex of 46, co-authored 110 publications receiving 24423 citations. Previous affiliations of Keisuke Okita include Kumamoto University & Hokkaido University.

Papers
More filters
Journal ArticleDOI

Induction and Enhancement of Cardiac Cell Differentiation from Mouse and Human Induced Pluripotent Stem Cells with Cyclosporin-A

TL;DR: Results provide a technological basis to obtain functional cardiomyocytes from iPSCs and show various cardiac marker expressions, synchronized calcium transients,Cardiomyocyte-like action potentials, pharmacological reactions, and ultra-structural features as cardiomeocytes.
Journal ArticleDOI

Epigenetic regulation of the nuclear-coded GCAT and SHMT2 genes confers human age-associated mitochondrial respiration defects

TL;DR: It is shown that reprogramming of elderly fibroblasts restores age-associated mitochondrial respiration defects, indicating that these aging phenotypes are reversible and are similar to differentiation phenotypes in that both are controlled by epigenetic regulation, not by mutations in either the nuclear or the mitochondrial genome.
Journal ArticleDOI

Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells.

TL;DR: The iPS cell‐derived DCs (iPS‐DCs) possessed the characteristics of DCs including the capacity of T‐cell‐stimulation, antigen‐processing and presentation and cytokine production, and DNA microarray analyses revealed the upregulation of genes related to antigen‐presenting functions during differentiation into iPS‐ DCs and similarity in gene expression profile in iPS•DCs and bone marrow cell‐ derived DCs.
Journal ArticleDOI

Induction of pluripotency by defined factors

TL;DR: Studies of the mechanisms underlying the reprogramming and establishment of non-integration methods contribute evidence to resolve the safety concerns associated with iPS cells.